The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: control, exercise.
- Who it may be relevant to
- Registry conditions: Erectile Dysfunction, Premature Ejaculation. Basic parameters: 25 years — 45 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation: a Randomized Controlled Trial.
Overview
The aim is to investigate the effectiveness of exercise in the treatment of erectile dysfunction and premature ejaculation.
Detailed description
The study was designed as a randomized controlled trial. Participants were divided into two equal groups: a control group and an exercise group. Patients in the control group were followed with normal conventional medical treatment, while participants in the exercise group underwent an 8-week, 3-day-a-week exercise program. All participants were evaluated before and after treatment using the Index of Erectile Function, the World Health Organization Quality of Life Short Form, and the Premature Ejaculation Diagnostic Tool.
Interventions
- Other control
Patients in the control group will be followed with normal conventional medical treatment. - Other exercise
Participants in the exercise group will undergo an 8-week, 3-day-a-week exercise program.
Primary outcome measures
- International Index of Erectile Dysfunction [Time frame: 10 weeks]
- Premature Ejaculation Diagnostic Tool [Time frame: 10 weeks]
Eligibility criteria
Inclusion criteria
- Male individuals aged 25-45 years
- Individuals diagnosed with erectile dysfunction and premature ejaculation
- Individuals who voluntarily agree to participate in the study and sign the informed consent form
- Individuals who have the physical and cognitive capacity to participate in pelvic floor physiotherapy applications
Exclusion criteria
- Individuals with a history of surgery in the pelvic region
- Individuals with a diagnosis of neurological disease or neurological disorder that may affect pelvic floor muscle function
- Presence of active infection, inflammation, or painful pathology in the pelvic region
- Individuals who regularly use medications that significantly affect sexual function
- Individuals with serious psychiatric illness or cognitive impairment that may hinder study compliance
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Uskudar university — Istanbul
Publications
- Yaacov D, Nelinger G, Kalichman L. The Effect of Pelvic Floor Rehabilitation on Males with Sexual Dysfunction: A Narrative Review. Sex Med Rev. 2022 Jan;10(1):162-167. doi: 10.1016/j.sxmr.2021.02.001. Epub 2021 Apr 27. PMID 33931383
- Sahin E, Brand A, Cetindag EN, Messelink B, Yosmaoglu HB. Pelvic physical therapy for male sexual disorders: a narrative review. Int J Impot Res. 2025 Dec;37(12):941-949. doi: 10.1038/s41443-025-01034-5. Epub 2025 Feb 27. PMID 40016382
- Niu C, Ventus D, Wen G, Santtila P. Associations between self-reports of physical activity, interoceptive awareness, autonomic regulation, premature ejaculation, and erectile dysfunction in Chinese men. Int J Impot Res. 2025 Dec;37(12):992-1001. doi: 10.1038/s41443-025-01072-z. Epub 2025 Apr 19. PMID 40251377
Identifiers
NCT: NCT07442396 · Uskudar93